One thing you can all bet on is old Pete et al are the ones manipulating the stock
check out the bio
Mr. Friedli has been a director of Osiris since January 1996, except for the period between February and June 2004. Since 1986, he has been a principal of the investment-banking firm Friedli Corporate Finance, Inc., a leading Swiss venture capital firm which has made significant investments in the biotechnology industry and has been the primary source of financing for Osiris. Mr. Friedli is also the President and a director of New Venturetec Ltd., a Swiss publicly traded investment company. Mr. Friedli has extensive experience as an independent investment manager in venture capital and has specialized in investments domiciled in the United States in the areas of biotechnology and technology.
I know of several issues that will stick it up the #$%$ of any lead plaintiff. Mdxg receives new FDA letter and only has to relabel amniofix, stock doubles, Medtronic sales are factored in for 2014, stock doubles, someone takes a run at mdxg, stock triples. These ambulance lawyers are idiots and hover around negative as well as positive news stories. This stock is just about ready to explode, you can feel it in the tight rubber band range and light volume, we break 5.75 on closing basis and it is off to the races.